On 15 November, the GSQ is organizing a Special Seminar with Professor Johannes A. Langendijk from the Comprehensive Cancer Center, University Medical Center Groningen (UMCG) in the Netherlands. In this seminar, Prof. Langendijk will give a talk relating to a “Model-based Approach” which better enables the most appropriate treatment to be selected between proton therapy or radiation therapy, based on differences in NTCP. In the Netherlands, due to significant efforts made by Prof. Langendijk and his team, proton therapy will start to be covered by insurance beginning from this autumn in cases where a more than 5 percent gap is anticipated in Grade 3 toxicity between proton and radiation therapy. This is a truly unique opportunity to hear discussion on cutting-edge personalized radiation oncology based on real world data. Please come and join us to get to know the innovative research!
Time and Date: 18:00-19:00, 15 November (Wed), 2017
Lecture Title: Evidence-based selection for and validation proton therapy: The model-based approach.
Venue: Special Conference Room, Faculty of Medicine, Hokkaido University
http://www.med.hokudai.ac.jp/en/general/floor/#build-inf
Language: English
Poster: Poster_Special_Seminar2017_1115
Admission: Free. Advanced registration is NOT required
Contact: Global Station for Quantum Medical Science and Engineering (GSQ)
Tel:+81-11706-8511 / Email: gsq@oia.hokudai.ac.jp
